Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/89684
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRodrigues, D.-
dc.contributor.authorButler, L.-
dc.contributor.authorEstelles, D.-
dc.contributor.authorde Bono, J.-
dc.date.issued2014-
dc.identifier.citationJournal of Pathology, 2014; 232(2):178-184-
dc.identifier.issn0022-3417-
dc.identifier.issn1096-9896-
dc.identifier.urihttp://hdl.handle.net/2440/89684-
dc.descriptionArticle first published online: 10 DEC 2013-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityDaniel Nava Rodrigues, Lisa M Butler, David Lorente Estelles and Johann S de Bono-
dc.language.isoen-
dc.publisherWiley-
dc.rightsCopyright © 2013 Pathological Society of Great Britain and Ireland-
dc.source.urihttp://dx.doi.org/10.1002/path.4272-
dc.subjectmolecular pathology; prostate cancer; castration-resistant; targeted therapy-
dc.titleMolecular pathology and prostate cancer therapeutics: from biology to bedside-
dc.typeJournal article-
dc.identifier.doi10.1002/path.4272-
pubs.publication-statusPublished-
dc.identifier.orcidButler, L. [0000-0003-2698-3220]-
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.